tradingkey.logo
搜索

Catheter Precision Inc

VTAK
添加自选
0.790USD
-0.085-9.83%
收盘 07/02, 13:00美东报价延迟15分钟
2.13M总市值
亏损市盈率 TTM

Catheter Precision Inc

0.790
-0.085-9.83%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-9.83%

5天

-27.52%

1月

-22.55%

6月

-60.70%

今年开始到现在

-56.83%

1年

-82.12%

关键数据
0.841今开
0.842最高
252.87K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
9.39%换手率
0.865昨收
0.780最低
119.08K成交额
亏损市盈率静
0.22市净率
0.00%股息率 TTM
-51.23%ROA
15.68152周最高
0.70量比
-21.80M净利润
2.69M总股本
-10.4776每股收益TTM
-1.02Beta
-185.06%ROE
0.75052周最低
7.12%振幅
90.28%毛利率
2.13M总市值
-2.28回报/风险
6.68%风险率

TradingKey Catheter Precision Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Catheter Precision Inc当前公司基本面数据相对谨慎,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名153/204位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价38.00。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Catheter Precision Inc评分

相关信息

行业排名
153 / 204
全市场排名
442 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Catheter Precision Inc亮点

亮点风险
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
业绩高增长
公司营业收入稳步增长,连续3年增长85.29%
业绩增长期
公司处于发展阶段,最新年度总收入819.00K美元
估值低估
公司最新PE估值-0.08,处于3年历史低位
机构加仓
最新机构持股304.48K股,环比增加43.06%
活跃度增加
近期活跃度增加,过去20天平均换手率6.93

分析师目标

根据 0 位分析师
--
评级
38.000
目标均价
+1753.66%
涨幅空间

Catheter Precision Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Catheter Precision Inc简介

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
公司代码VTAK
公司Catheter Precision Inc
CEOJenkins (David A)
网址https://www.ramed.com/

常见问题

Catheter Precision Inc(VTAK)的当前股价是多少?

Catheter Precision Inc(VTAK)的当前股价是 0.79。

Catheter Precision Inc的股票代码是什么?

Catheter Precision Inc的股票代码是VTAK。

Catheter Precision Inc股票的52周最高点是多少?

Catheter Precision Inc股票的52周最高点是15.68。

Catheter Precision Inc股票的52周最低点是多少?

Catheter Precision Inc股票的52周最低点是0.75。

Catheter Precision Inc的市值是多少?

Catheter Precision Inc的市值是2.13M。

Catheter Precision Inc(VTAK)股票的每股收益(EPS TTM)是多少

Catheter Precision Inc(VTAK)股票的每股收益(EPS TTM)是-15.90。